Preparations of antimicrobials from biotechnological sources containing nuc
leic acids may serve as vector for the dissemination of resistance genes. A
n essential prerequisite for the acquisition of a new resistance phenotype
in a transformational scenario is the availability of physically intact DNA
molecules capable of transforming competent microorganisms. DNA is thought
re, be an easy target for catabolic processes when present in the natural
habitat of bacteria (eg. gastrointestinal tract, soil) due to the overall p
resence of nucleolytic enzymes. Aminoglycoside antibiotics are known to dis
play a strong affinity to nucleic acids rendering these compounds to be pri
mary candidates for exerting DNA protective functions in the gastrointestin
al tract when applied orally during antibiotic chemotherapy. Using a DNase
I protection assay it could be demonstrated that neomycin B at a concentrat
ion of 2 mM completely inhibited degradation of plasmid DNA in vitro. No in
hibition of degradation was observed with streptomycin and kanamycin and th
e non-aminoglycoside antibiotics oxytetracycline and ampicillin under ident
ical assay conditions. Thus, neomycin preparations may be able to promote s
tructural integrity of contaminating DNA-fragments in DNase-rich environmen
ts.